Canada Will Likely Miss WHO's Hepatitis C Elimination Target Canada Will Likely Miss WHO's Hepatitis C Elimination Target
More harm reduction strategies are needed to help eliminate hepatitis C by 2030, according to researchers.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 25, 2024 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Higher Hepatitis C Virus Cure Rates Seen With Facilitated Telemedicine
FRIDAY, April 12, 2024 -- Significantly higher hepatitis C virus cure rates are seen for patients receiving opioid treatment program-integrated facilitated telemedicine versus off-site hepatitis specialist referral, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
Start of a New Trend? Hepatitis C Cases Drop in the U.S.
(MedPage Today) -- New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday.
Experts are not sure whether the 6% decline is a statistical... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 4, 2024 Category: American Health Source Type: news
Hepatitis C cases dropped in the US. Health officials unsure if it's a blip or trend
Federal health officials say that new U.S. hepatitis C infections dropped slightly in 2022 (Source: ABC News: Health)
Source: ABC News: Health - April 3, 2024 Category: Consumer Health News Tags: Health Source Type: news
Telehealth Improves Hepatitis C Treatment in Patients With Opioid Use Disorder
(MedPage Today) -- Facilitated telemedicine integrated into an opioid treatment program led to better hepatitis C virus (HCV) cure rates compared with usual referral-based care, a randomized clinical trial showed.
In an intention-to-treat analysis... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 3, 2024 Category: Psychiatry Source Type: news
What is the infected blood scandal and how many people died?
Thousands were infected with HIV and hepatitis C, in the worst treatment disaster in NHS history. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 2, 2024 Category: Consumer Health News Source Type: news
Hepatitis C Treatments on the Horizon
WebMD looks at the treatments that may be available for hepatitis C in the next few years. (Source: WebMD Health)
Source: WebMD Health - March 26, 2024 Category: Consumer Health News Source Type: news
What is the infected blood scandal?
Thousands were infected with HIV and hepatitis C, in the worst treatment disaster in NHS history. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 14, 2024 Category: Consumer Health News Source Type: news
Unmet need for medication for opioid use disorder among persons who inject drugs in 23 U.S. cities - Handanagic S, Broz D, Finlayson T, Kanny D, Wejnert C.
BACKGROUND: Persons who inject drugs (PWID) are at increased risk of HIV and hepatitis C virus (HCV) infections and premature mortality due to drug overdose. Medication for opioid use disorder (MOUD), such as methadone or buprenorphine, reduces injecting b... (Source: SafetyLit)
Source: SafetyLit - March 12, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Treating Kids' HCV Early May Boost Lifetime Health Outcomes and Save Money
(MedPage Today) -- Treating hepatitis C virus (HCV) earlier in kids was associated with better lifetime clinical outcomes and lower healthcare costs compared with deferring treatment, a modeling study showed.
Projected life expectancy was longest... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 11, 2024 Category: Gastroenterology Source Type: news
Mayo Clinic Minute: What is hepatitis C?
It's estimated that 2 to 3 million people in the U.S. are living with the hepatitis C virus, and hundreds of thousands of them are undiagnosed. That's primarily because it tends to be asymptomatic in the initial stages until liver damage sets in decades later. A recent study coauthored by Dr. Karthik Gnanapandithan, a hospitalist at Mayo Clinic, found that nearly 40% of people with hepatitis C living in the U.S. are not even aware… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 11, 2024 Category: Databases & Libraries Source Type: news
CDC: Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
The Centers for Disease Control and Prevention (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) will hold a hybrid public meeting on April 9-10, 2024. Agenda items include discussions related to syndemic approach to testing, using prescription data to support the HIV care continuum, HIV and aging, advancing diagnosis of hepatitis C virus infection, updates from the Community Partnerships and Workforce workgroups, and more. Written comments are due by April 19, 2024, and requests to make oral comments should besubmitted by March ...
Source: Federal Register updates via the Rural Assistance Center - February 29, 2024 Category: Rural Health Source Type: news
LR-M category tied to lower survival in HCC resection patients
Non-liver cancer-specific malignant lesions (LR-M) on CT or MRI are tied to lower overall survival in patients with solitary hepatocellular carcinoma (HCC) undergoing resection, a study published February 27 in Radiology found.
Researchers led by Roberto Cannella, MD, from the University of Palermo in Italy also found that the presence of at least one non-targetoid feature is linked to increased recurrence risk, regardless of LI-RADS category.
“Overall, our results confirm that the LR-M category should be considered in addition to pathology,” Cannella and colleagues wrote.
The Liver Imaging Reporting and Data System...
Source: AuntMinnie.com Headlines - February 27, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: CT MRI Source Type: news
The Breakthrough Drug Whose Full Promise Remains Unrealized The Breakthrough Drug Whose Full Promise Remains Unrealized
With its approval in 2013, sofosbuvir revolutionized treatment for hepatitis C, but the goal of eliminating this disease is still decades away.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 22, 2024 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news
The Hepatitis C Crisis Epitomizes The Problems With U.S. Healthcare
There has been a cure for Hepatitis C since 2014, yet nearly four million Americans are living with the viral infection, according to American Liver Foundation. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2024 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
